Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon pathways, designed to reduce appetite and support weight management
Once the body makes this hormone, it is circulated throughout and received by receptors in the pancreas, intestines, heart, brain, and more
Retatrutide Is Still Investigational, but Treatment Options Are Available Now Retatrutide is not currently available as an FDA-approved prescription
Larsen TM, Dalskov SM, van Baak M, Jebb SA, Papadaki A, Pfeiffer AF, et al
Unlike prefilled pens, compounded semaglutide products lack standardized safety features, and the use of incorrect syringes can introduce dosing variability and confusion
US$ 27.45
US$ 20.72
US$ 25.85
